AI assistant
ZEVRA THERAPEUTICS, INC. — Director's Dealing 2021
May 17, 2021
32811_dirs_2021-05-17_3ee496b3-cb92-423c-84d7-10b98ca320f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2021-05-10
Reporting Person: Braun Samuel J (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| COMMON STOCK | 3060000 | Direct |
| COMMON STOCK | 68000 | Indirect |
| COMMON STOCK | 15000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| CALL OPTION (OBLIGATION TO BUY) | $ | 2021-08-20 | COMMON STOCK (2000) | Direct |
Footnotes
F1: Includes 60,000 shares held in a jointly-owned account over which the reporting person exercises sole investment discretion. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F2: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F3: The Call Options represent the reporting person's obligation to purchase the referenced shares if the trading price on the expiration date exceeds $10 per share. Otherwise, exercise of the options is at the holder's discretion.